Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Practical experiences with insulin infusion pumps.

Acta Medica Scandinavica. Supplementum

|January 1, 1983

Summary

This summary is machine-generated.

Continuous subcutaneous insulin infusion (CSII) shows promise for insulin-dependent diabetics, but patient factors, pump reliability, and strict metabolic control effects on complications need further evaluation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A modelling study of the budget impact of improved glycaemic control in adults with Type 1 diabetes in the UK.

Diabetic medicine : a journal of the British Diabetic Association·2019

Same author

Is insulin pump therapy effective in Type 1 diabetes?

Diabetic medicine : a journal of the British Diabetic Association·2018

Same author

Investigating incretin-based therapies as a novel treatment for depression in type 2 diabetes: Findings from the South London Diabetes (SOUL-D) Study.

Primary care diabetes·2015

Same author

Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review.

Diabetic medicine : a journal of the British Diabetic Association·2015

Same author

Banting Memorial Lecture 2014* Technology and diabetes care: appropriate and personalized.

Diabetic medicine : a journal of the British Diabetic Association·2014

Same author

Variations in the quality and sustainability of long-term glycaemic control with continuous subcutaneous insulin infusion.

Diabetic medicine : a journal of the British Diabetic Association·2014

Area of Science:

Endocrinology
Metabolic Diseases
Medical Devices

Background:

Insulin-dependent diabetes mellitus requires intensive management.
Continuous subcutaneous insulin infusion (CSII) offers an alternative to multiple daily injections.
Evaluating CSII's routine use necessitates understanding its clinical implications.

Purpose of the Study:

To assess the viability of continuous subcutaneous insulin infusion (CSII) as a standard treatment for insulin-dependent diabetics.
To review clinical considerations impacting CSII adoption and efficacy.

Main Methods:

Discussion of recent evidence regarding CSII.
Analysis of patient acceptance and tolerance of insulin pump systems.
Evaluation of potential pump malfunctions and their consequences.

Related Experiment Videos

Assessment of the impact of strict metabolic control achieved through CSII on diabetic complications.

Main Results:

Patient acceptance and system usability are critical for CSII success.
The risk and impact of insulin pump malfunction require careful management.
Strict metabolic control via CSII may influence the progression of diabetic complications.

Conclusions:

The routine use of CSII depends on addressing patient-related factors, pump reliability, and the long-term effects of tight glycemic control on diabetic complications.
Further research and clinical experience are needed to optimize CSII therapy.